VeraFuse Flowable DBM Putty in 0.7cc Syringe (VF25070)

MSRP: $129.95
$99.00
(You save $30.95 )
(No reviews yet) Write a Review
SKU:
PST-VERA-VF25070
  • A 0.7cc demineralized bone matrix (DBM) allograft in a flowable syringe, used primarily in dental and oral surgical procedures to promote bone regeneration

Uses

  • Socket Preservation:
    • Placed in extraction sites to maintain ridge volume
  • Ridge Augmentation:
    • Used to increase the width or height of the alveolar ridge
  • Sinus Lift Procedures:
    • Fills the floor of the maxillary sinus to prepare for implants
  • Periodontal Defects:
    • Treats bone loss around teeth caused by gum disease
  • Cystic Voids:
    • Fills spaces left after the removal of cysts or benign bone tumors

Features

  • 100% Human Bone Tissue:
    • Contains no extrinsic carriers or fillers (like glycerol or CMC), ensuring the graft's potency isn't diluted
  • Flowable Consistency:
    • Packaged in a pre-filled 0.7cc syringe (VF25070) for easy dispensing and adaptability to irregular voids
  • Dual Biological Action:
    • Combines osteoinductive properties (contains growth factors like BMPs to trigger cell differentiation) with an osteoconductive scaffold (supports new bone growth)
  • Ready-to-Use:
    • Requires no reconstitution or preparation time and can be stored at ambient room temperature
  • Sterile Processing:
    • Gamma irradiated to a Sterility Assurance Level (SAL) of 10⁻⁶ following FDA and AATB guidelines

 Benefits

  • Superior Handling:
    • The putty is resistant to washing away or migrating during irrigation (lavage), which keeps the graft stable at the surgical site
  • High Biocompatibility:
    • Because it is entirely derived from human bone, it minimizes the risk of foreign body reactions often associated with synthetic carriers
  • Accelerated Healing:
    • The high concentration of natural bone morphogenetic proteins (BMPs) can lead to faster tissue regeneration compared to mineralized materials
  • Efficient Delivery:
    • The syringe allows for direct application, potentially reducing surgical "chair time" and simplifying the procedure for the clinician